K Number
K020668
Device Name
ALOKA SSD-1000 DIAGNOSTIC ULTRASOUND SYSTEM, MODELS ASU-1003, UST-9121, UST-9124
Manufacturer
Date Cleared
2002-07-10

(131 days)

Product Code
Regulation Number
892.1560
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: For ASU-1003: Fetal, Transvaginal. Mixed mode operation includes B/M-Mode. For UST-9121: Abdominal. Mixed mode operation includes B/M. For UST-9124: Fetal, Transvaginal. Mixed mode operation includes B/M. The transducers are to be used for diagnostic ultrasound imaging in Urological, Abdominal, Intraoperative, Surgical and Endoscopic applications.
Device Description
Diagnostic Ultrasound Transducers
More Information

Not Found

No
The summary does not mention AI, ML, or any related terms, and the device description is limited to ultrasound transducers.

No
The device is described as "Diagnostic Ultrasound Transducers" and its "Intended Use" explicitly states "Diagnostic ultrasound imaging or fluid flow analysis", without any mention of therapeutic application.

Yes
The "Intended Use / Indications for Use" section explicitly states "Diagnostic ultrasound imaging or fluid flow analysis of the human body". Also, the "Device Description" clearly labels the device as "Diagnostic Ultrasound Transducers".

No

The device description explicitly states "Diagnostic Ultrasound Transducers," which are hardware components. The intended use also describes diagnostic ultrasound imaging, which requires hardware transducers.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
  • Device Function: The provided description clearly states that this device is a Diagnostic Ultrasound Transducer. Ultrasound imaging works by sending sound waves into the body and receiving the echoes to create images. This is an in vivo (within the living body) diagnostic method, not an in vitro one.
  • Intended Use: The intended use describes imaging or fluid flow analysis of the human body, not analysis of samples taken from the body.

Therefore, based on the provided information, this device falls under the category of diagnostic imaging devices, not in vitro diagnostics.

N/A

Intended Use / Indications for Use

The transducers are to be used for diagnostic ultrasound imaging in Urological, Abdominal, Intraoperative, Surgical and Endoscopic applications.

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Aloka SSD-1000:
Clinical Application:

  • Fetal: Modes of operation: B, M. Combined (specify): See Below.
  • Abdominal: Modes of operation: B, M. Combined (specify): See Below.
  • Intraoperative (specify): Modes of operation: B, M. Combined (specify): See Below.
  • Intraoperative Neurological: Modes of operation: B, M. Combined (specify): See Below.
  • Pediatric: Modes of operation: B, M. Combined (specify): See Below.
  • Small Organ (specify): Modes of operation: B, M. Combined (specify): See Below.
  • Neonatal Cephalic: Modes of operation: B, M. Combined (specify): See Below.
  • Adult Cephalic: Modes of operation: B, M. Combined (specify): See Below.
  • Cardiac: Modes of operation: B, M. Combined (specify): See Below.
  • Transrectal: Modes of operation: B, M. Combined (specify): See Below.
  • Transvaginal: Modes of operation: B, M. Combined (specify): See Below.
  • Peripheral Vascular: Modes of operation: B, M. Combined (specify): See Below.
  • Laparoscopic: Modes of operation: B, M. Combined (specify): See Below.
    Additional Comments: Mixed mode operation includes B/M-Mode

ASU-1003:
Clinical Application:

  • Fetal: Modes of operation: B, M. Combined (specify): See Below.
  • Transvaginal: Modes of operation: B, M. Combined (specify): See Below.
    Additional Comments: Mixed mode operation includes B/M,

UST-9121:
Clinical Application:

  • Abdominal: Modes of operation: B, M. Combined (specify): See Below.
    Additional Comments: Mixed mode operation includes B/M

UST-9124:
Clinical Application:

  • Fetal: Modes of operation: B, M. Combined (specify): See Below.
  • Transvaginal: Modes of operation: B, M. Combined (specify): See Below.
    Additional Comments: Mixed mode operation includes B/M,

Product codes (comma separated list FDA assigned to the subject device)

90 ITX, 90 IYO

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound

Anatomical Site

Urological, Abdominal, Intraoperative, Surgical, Endoscopic, Fetal, Intraoperative Neurological, Pediatric, Small Organ, Neonatal Cephalic, Adult Cephalic, Cardiac, Transrectal, Transvaginal, Peripheral Vascular, Laparoscopic

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K012253, K012080

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

| 1

1
8.00 | forests | 19 | 2002
ﮨﮯ ﮐﮧ |

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Image /page/0/Picture/1 description: The image shows a handwritten text that appears to be a signature or a short note. The text includes a combination of cursive letters and numbers, with the numbers '68' clearly visible at the end. The writing style is somewhat stylized, with loops and curves that are characteristic of handwriting.

510(k) Summary

る。

This summary statement complies with 21 CFR, section 807.92 as amended March 14, 1995.

| Submitter's Name and Address | Aloka Co., Ltd.
10 Fairfield Boulevard
Wallingford, CT 06492 |
|-----------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact's Name, Title, Address and Telephone Number | Kelvin Burroughs
Regulatory Affairs/Quality Assurance Coordinator
Aloka Co., Ltd.
10 Fairfield Boulevard
Wallingford, CT 06492
(203) 269-5088 |
| Device Proprietary Name | ASU-1003
UST-9121
UST-9124 |
| Device Common Name | Diagnostic Ultrasound Transducers |
| Classification | The charts below list the Regulatory Class and Device Codes. |

SubjectDescription
Regulatory ClassClass II
Review CategoryTier II
CodeDescriptionRegulation
90 ITXTransducer, Ultrasonic, Diagnostic892.1570

Continued on next page

1

510(k) Summary, Continued

| Identification of
predicate

devicesThe following is a list of probes submitted in this notification, their predicate devices and the 510(k) clearance numbers.
Subject TransducerPredicate TransducerPredicate Transducer
510(k)/Appendix E
ASU-1003ASU-1000C-3.5K012253
UST-9121UST-9114-3.5K012080
UST-9124UST-9103-5K012253
ProbesProbes that are the subject of a submitted and cleared 510(k) for the SSD-
1400 have already been added to the SSD-1000. New and additional probes for used with the SSD-1000 are the subjects of this submission.
Intended UseThe transducers are to be used for diagnostic ultrasound imaging in Urological, Abdominal, Intraoperative, Surgical and Endoscopic applications.

್ರಾ

របស់ :

2

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right. The profiles are stacked on top of each other and are connected by a flowing line.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUL 1 0 2002

Mr. Richard J. Cehovsky Regulatory Affairs/Quality Assurance ALOKA Co., Ltd. U.S.A. 10 Fairfield Boulevard WALLINGFORD CT 06492-7502

Re: K020668

Trade Name: Aloka SSD-1000 Diagnostic Ultrasound System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasound pulsed echo imaging system Regulation Number: 21 CFR 892.1570 Regulaton Name: Diagnostic ultrasound transducer Regulatory Class: II Product Code: 90 IYO and ITX Dated: May 8, 2002 Received: May 9, 2002

Dear Mr. Cehovsky:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling. and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the Aloka SSD-1000, as described in your premarket notification:

Transducer Model Number

ASU-1003
UST-9121
UST-9124

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device

3

Page 2 - Mr. Cehovsky

can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G. (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.

The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801, please contact the Office of Compliance at (301) 594-4591. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or at (301) 443-6597 or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".

4

If you have any questions regarding the content of this letter, please contact Rodrigo C. Perez at (301) 594-1212.

Sincerely yours,

Nancy C Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure(s)

5

System/TransducerSystem
ModelSSD-1000
510(k) NumberAppendix E

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationModes of operation
ABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(specify)Other
(specify)
Opthalmic
FetalEESee Below
AbdominalEESee Below
Intraoperative (specify)EESee Below
Intraoperative NeurologicalEESee Below
PediatricEESee Below
Small Organ (specify)EESee Below
Neonatal CephalicEESee Below
Adult CephalicEESee Below
CardiacEESee Below
Transesophageal
TransrectalEESee Below
TransvaginalEESee Below
Transurethral
Intravascular
Peripheral VascularEESee Below
LaparoscopicEESee Below
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Other

ly cleared by FDA; E-added under Appendix E;

Additional Comments:

Mixed mode operation includes B/M-Mode

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Brogdon
(Division Sign-Off)

Division of Reproductive and Radiological Devices 510(k) Number

Aloka Company, Ltd.

Additional Probes for SSD-5000

Page

6

System/TransducerTransducer
ModelASU-1003
510(k) Number

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationModes of operation
ABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(specify)Other
(specify)
Ophthalmic
FetalNNSee Below
Abdominal
Intraoperative (specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neonatal Cephalic
Adult Cephalic
Cardiac
Transesophageal
Transrectal
TransvaginalNNSee Below
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Other

N=new indication; P= previously cleared by FDA; E= added under Appendix E;

Additional Comments:

Mixed mode operation includes B/M,

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy Brogdon

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number J

Aloka Company, Ltd.

Additional Probes for SSD-5000

7

System/TransducerTransducer
ModelUST-9121
510(k) NumberK003739

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationModes of operation
ABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(specify)Other
(specify)
Opthalmic
Fetal
AbdominalPPSee Below
Intraoperative (specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neonatal Cephalic
Adult Cephalic
Cardiac
Transesophageal
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Other

N= new indication; P= previously cleared by FDA; E= added under Appendix E;

Additional Comments:

Mixed mode operation includes B/M

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C. Brogdon

(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K020667

Aloka Company, Ltd.

Additional Probes for SSD-5000

です
『 Page

8

System/TransducerTransducer
ModelUST-9124
510(k) NumberK003739

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationModes of operation
ABMPWDCWDColor
DopplerAmplitude
DopplerColor
Velocity
ImagingCombined
(specify)Other
(specify)
Opthalmic
FetalPPSee Below
Abdominal
Intraoperative (specify)
Intraoperative Neurological
Pediatric
Small Organ (specify)
Neonatal Cephalic
Adult Cephalic
Cardiac
Transesophageal
Transrectal
TransvaginalPPSee Below
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional
Musculo-skeletal Superficial
Other

N= new indication; P= previously cleared by FDA; E= added under Appendix E;

Additional Comments:

Professor Section Monaries & Particular Researce Most Province

Mixed mode operation includes B/M,

(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109)

Nancy C Hodgon

(Division Sign-Off) Division of Reproductive, Abdominal and Radiological Devices 510(k) Number _